IPOFeb 8
Biotech IPOs Raise $1B in Biggest Week Since 2021
Four drug companies went public this week raising nearly $1 billion combined, led by Eikon Therapeutics' $381M offering — the largest biotech IPO since 2024.
Affirm posts first GAAP operating profit at $118M on 30% revenue growth, with its card business and merchant network driving the BNPL leader's breakout quarter.
Four drug companies went public this week raising nearly $1 billion combined, led by Eikon Therapeutics' $381M offering — the largest biotech IPO since 2024.
Amazon, Alphabet, Meta, Microsoft, and Oracle have committed a combined $650 billion in capital spending for 2026, with 75% aimed at AI infrastructure.
Goldman Sachs estimates consumers will absorb 67% of tariff costs by mid-2026, as the S&P 500's CAPE ratio hits 39.9 — a level last seen during the dot-com peak.